|
PARI Pharma products are currently being used in more
than 20 clinical trials for new medications
delivered by nebulizer. PARI Pharma has a proven track
record for device supply and coordination of
clinical trials with pharma companies. In
addition, PARI Pharma products are listed in the
package insert for many current medications
including those indicated with an
*
below:
Pulmozyme® (Genentech) for cystic fibrosis
*
Pulmicort Respules® (AstraZeneca) for asthma
*
TOBI® (Novartis) for cystic fibrosis
*
DuoNeb® (Dey) for COPD, asthma
*
AccuNeb® (Dey) for asthma
*
Xopenex® (Sepracor) for asthma
*
Aztreonam lysinate (Gilead Sciences) for cystic
fibrosis
Denufosol tetrasodium (Inspire) for cystic
fibrosis
|
